Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 Jun 13;294(6586):1510–1511. doi: 10.1136/bmj.294.6586.1510

Influence of non-steroidal anti-inflammatory drugs on the outcome of faecal occult blood tests in screening for colorectal cancer.

G Pye, K C Ballantyne, N C Armitage, J D Hardcastle
PMCID: PMC1246669  PMID: 3111616

Abstract

Non-steroidal anti-inflammatory drugs have been accused of causing false positive results in faecal occult blood tests for colorectal cancer. A study was therefore performed in 10,931 people undergoing faecal occult blood screening tests to assess the effect of these drugs on the predictive value of a positive test result. Those with a positive result were interviewed and a full drug history was taken before they underwent a full colorectal examination. Of the 455 people with a positive result, 50 were taking non-steroidal anti-inflammatory drugs: 10 (20%) had colonic neoplasia. Of the 405 who were not taking non-steroidal anti-inflammatory drugs, 129 (32%) had colonic neoplasia. These detection rates were not significantly different, and the predictive value of a positive result for an adenoma larger than 1 cm was 14% in the group not taking anti-inflammatory drugs and 26% in the group taking them (not significant). These results suggest that a finding of occult faecal blood cannot be attributed to upper gastrointestinal tract bleeding caused by non-steroidal anti-inflammatory drugs and should be followed by a thorough colorectal examination.

Full text

PDF
1510

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bahrt K. M., Korman L. Y., Nashel D. J. Significance of a positive test for occult blood in stools of patients taking anti-inflammatory drugs. Arch Intern Med. 1984 Nov;144(11):2165–2166. [PubMed] [Google Scholar]
  2. Fries J. F., Britton M. C. Fenoprofen calcium in rheumatoid arthritis. A controlled double-blind crossover evaluation. Arthritis Rheum. 1973 Sep-Oct;16(5):629–634. doi: 10.1002/art.1780160507. [DOI] [PubMed] [Google Scholar]
  3. Hardcastle J. D., Armitage N. C., Chamberlain J., Amar S. S., James P. D., Balfour T. W. Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer. 1986 Jul 15;58(2):397–403. doi: 10.1002/1097-0142(19860715)58:2<397::aid-cncr2820580235>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  4. Roth S. H. Nonsteroidal anti-inflammatory drug gastropathy. We started it--can we stop it? Arch Intern Med. 1986 Jun;146(6):1075–1076. [PubMed] [Google Scholar]
  5. Somerville K., Faulkner G., Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986 Mar 1;1(8479):462–464. doi: 10.1016/s0140-6736(86)92927-2. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES